Securities PURCHASE AGREEMENTSecurities Purchase Agreement • June 25th, 2019 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of June 21, 2019, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PURE BIOSCIENCE, INC. AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 25th, 2019 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Amendment (the “Amendment”) to Securities Purchase Agreement dated May 7, 2019 (the “Agreement “) is made and entered into effective as of June 21, 2019 (the “Effective Date”), by and among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). Capitalized terms used but not otherwise defined herein shall have the same meanings as set forth in the Agreement.
